GH Research (GHRS)
NASDAQ: GHRS
· Real-Time Price · USD
12.13
0.57 (4.93%)
At close: Jun 03, 2025, 3:59 PM
11.48
-5.36%
After-hours: Jun 03, 2025, 05:31 PM EDT
4.93% (1D)
| Bid | 8.89 |
| Market Cap | 752.4M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -42.11M |
| EPS (ttm) | -0.79 |
| PE Ratio (ttm) | -15.35 |
| Forward PE | -7.74 |
| Analyst | Buy |
| Ask | 13.44 |
| Volume | 281,562 |
| Avg. Volume (20D) | 197,393 |
| Open | 11.38 |
| Previous Close | 11.56 |
| Day's Range | 10.96 - 12.19 |
| 52-Week Range | 6.00 - 20.50 |
| Beta | 0.86 |
About GHRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GHRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GHRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-9.28%
GH Research shares are trading lower after announc...
Unlock content with
Pro Subscription
4 months ago
+69.72%
GH Research shares are trading higher after the company's inhalable depression treatment GH001 met the primary endpoint in its Phase 2b trial, showing symptom reduction.
